(NewsDirect)
NuGen Medical Devices executive chairmanTony Di Benedetto joined Steve Darling from Proactive to providedetails about the company that is developing the next generation ofneedle-free technologies for both humans and animals.
DiBenedetto shares with Proactive more about the technology behindproducts InsuJet and PetJet and also about an assessment andfeasibility study in the Netherlands of InsuJet for Semaglutide or itsmore widely known name Ozempic.
ContactDetails
Proactive Investors
+1 604-688-8158
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.